Interleukin 12: still a promising candidate for tumor immunotherapy?

Lasek, Witold; Zagozdzon, Radoslaw; Jakobisiak, Marek

Lasek, Witold; Zagozdzon, Radoslaw; Jakobisiak, Marek.

Affiliation

Lasek W; Department of Immunology, Centre of Biostructure Research, Medical University of Warsaw, Banacha 1a, "F" Bldg, 02-097, Warsaw, Poland, witold.lasek@wum.edu.pl.

Cancer Immunol Immunother ; 63(5): 419-35, 2014 May.

Article in En | MEDLINE | ID: mdl-24514955

Subject(s)

Immunotherapy/methods; Interleukin-12/therapeutic use; Neoplasms/therapy; Animals; Cancer Vaccines/immunology; Cancer Vaccines/therapeutic use; Genetic Therapy/methods; Humans; Interleukin-12/immunology; Neoplasms/immunology

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Interleukin-12 / Immunotherapy / Neoplasms Type of study: Prognostic_studies Limits: Animals / Humans Language: En Journal: Cancer Immunol Immunother Journal subject: ALERGIA E IMUNOLOGIA / NEOPLASIAS / TERAPEUTICA Year: 2014 Document type: Article

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google